HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$23.23
Day range
$22.57 - $23.96
Year range
$6.13 - $44.54
Market cap
1.26B USD
Avg Volume
692.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 71.31M | 521.94% |
Net income | -240.44M | -357.08% |
Net profit margin | — | — |
Earnings per share | -1.39 | — |
EBITDA | -71.30M | -28.26% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -90.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -240.44M | -357.08% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
Employees
167
